This site is intended for healthcare professionals
Magnifying glass on blue background; searching for results

Find disease awareness content and relevant supporting materials

Learning Zone 472 Events 16 News 19947 Drugs 42558 Trials 863 Guidelines 640 Journals 1966
Filter results
Sort by:
Relevance
to
Image placeholder
Event
12/06/25

EHA2025

Find out about the upcoming EHA2025 Congress, including location and how to register, plus related resources for healthcare professionals.

Blue test tubes arranged in a line, disappearing into the background
Drug news
18/03/25

OPKO and Entera Bio Collaboration

OPKO Health and Entera Bio collaborate to advance oral dual-agonist GLP-1/glucagon peptide for obesity treatment.

  • 1 min read
Blue test tubes arranged in a line, disappearing into the background
Drug news
18/03/25

EneboPTH Meets Primary Endpoint

AstraZeneca's EneboPTH meets primary endpoint of normalizing serum calcium in hypoparathyroidism patients in CALYPSO Phase III trial.

  • 1 min read
Guidelines
Guideline
01/10/23

Current clinical management of CIDP with immunoglobulins in France: An expert opinion

The French expert opinion on managing chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) emphasizes individualized treatment strategies using intravenous immunoglobulins (Ig). The guidelines highlight the importance of validated tools for monitoring treatment response at diagnosis, initiation, and follow-up stages.

  • 1 min read
Blue test tubes arranged in a line, disappearing into the background
Drug news
25/03/25

FDA Approves Keytruda Combo Therapy

FDA approves Keytruda, Herceptin, and chemotherapy for HER2-positive gastric cancer expressing PD-L1.

  • 1 min read
Blue test tubes arranged in a line, disappearing into the background
Drug news
25/03/25

FDA Issues Response for Camrelizumab

FDA issues second response letter for Camrelizumab and Rivoceranib for metastatic hepatocellular carcinoma.

  • 1 min read
Focused audience members view a panel discussion at a conference. The image captures engagement and diverse professionals in a blurred background.
HRR Mutation Testing in mPC
27/03/25

Congress highlights

Catch up with the latest data presented at major oncology and urology congresses on HRR testing in the prognosis and treatment of mPC.

  • 1 min read
Blue test tubes arranged in a line, disappearing into the background
Drug news
27/03/25

Positive Phase II Data for WVE-N531 in DMD

Phase II trial of WVE-N531 shows positive results in boys with Duchenne muscular dystrophy amenable to exon 53 skipping.

  • 5 min read
Blue test tubes arranged in a line, disappearing into the background
Drug news
24/03/25

FDA Decision on ProSense for Breast Cancer

DA to decide on ProSense marketing for early-stage, low-risk breast cancer with endocrine therapy by Q1 2025.

  • 1 min read
Blue test tubes arranged in a line, disappearing into the background
Drug news
17/03/25

FDA Expands Iluvien Label

FDA approves expanded label for Iluvien (fluocinolone acetonide) for chronic non-infectious uveitis treatment.

  • 1 min read
See more